Oct 31, 2018
The Department of Health and Human Services today proposed implementing on Jan. 1 its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers.
Sep 18, 2018
Leaders from the AHA and individual 340B hospitals today came together to announce new principles for ensuring good stewardship of the 340B program. The new AHA-led initiative seeks to strengthen the 340B program by increasing transparency while helping 340B hospitals better publicly communicate…
Jul 21, 2021
The Centers for Medicare & Medicaid Services July 19 released its calendar year 2022 outpatient prospective payment system/ambulatory surgical center proposed rule.
Jul 20, 2021
Download the AHA Special Bulletin: CMS Issues Hospital Outpatient/ASC Proposed Rule, Including Modifications to Price Transparency Rule
Jul 13, 2021
Congress is currently considering legislation that would provide temporary relief for any hospitals participating in the 340B program that had to leave the program due to patient mix changes as a result of the COVID-19 pandemic.
Jul 7, 2021
Congress is currently considering legislation that would provide temporary relief for any hospitals participating in the 340B program that had to leave the program due to changes in their patient mix as a result of the COVID-19 pandemic.
Jul 2, 2021
The Supreme Court of the United States today decided to take up AHA’s petition asking to reverse a federal appeals court decision that significantly cuts payments to certain hospitals that participate in the 340B Drug Pricing Program, threatening access to care in communities.
Jul 2, 2021
We are pleased that the U.S. Supreme Court has agreed to hear the compelling arguments in our case on payments cuts to the 340B drug pricing program that are adversely impacting care to patients.
Jun 24, 2021
Amicus Brief Eli Lilly v Cochran Re 340B Contract Pharmacy – Intervention filed June 23, 2021.